Drug profile · INN
conivaptan hydrochloride
VAPRISOL
conivaptan hydrochloride (VAPRISOL) is a vasopressin v1a receptor antagonist. Associated with CUMBERLAND PHARMACEUTICALS INC. Route of administration: injection. Current US regulatory status: approved.
Drug details — conivaptan hydrochloride
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 7
- Programs
- 6
- Data quality
- 0.89
Quick answer
conivaptan hydrochloride (VAPRISOL) is a vasopressin v1a receptor antagonist. Associated with CUMBERLAND PHARMACEUTICALS INC. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Vasopressin V1a receptor antagonist
Primary target: Vasopressin V1a receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
-
US 12161632
Compositions and methods of treating cardiac fibrosis with ifetroban
granted -
US 10925860
Compositions and methods of treating cardiac fibrosis with ifetroban
granted -
US 10583126
Compositions and methods of treating cardiac fibrosis with ifetroban
granted -
US 10314824
Compositions and methods of treating cardiac fibrosis with ifetroban
granted -
US 10016399
Compositions and methods of treating cardiac fibrosis with ifetroban
granted -
US 9693998
Compositions and methods of treating cardiac fibrosis with ifetroban
granted -
US 6727286
Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid
expired
Frequently asked questions
What is conivaptan hydrochloride?
conivaptan hydrochloride (VAPRISOL) is a vasopressin v1a receptor antagonist. Associated with CUMBERLAND PHARMACEUTICALS INC. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for conivaptan hydrochloride?
VAPRISOL is a marketed brand name for conivaptan hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of conivaptan hydrochloride?
conivaptan hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.